Driving The UK’s Leadership in Vaccine Research And Innovation
This Reformer Thoughts discusses how the UK can drive innovation and research into vaccines, even beyond the Covid-19 pandemic.
This publication brings together experts from Government, the scientific research community, and the life sciences sector to discuss the future of vaccination and how the UK can retain its leading position in vaccine research. This publication has kindly been supported by Sanofi.
Thank you to all of our contributors which include:
- Claudia Martinez, Health Policy Fellow, Reform
- Dr Doug Brown, Chief Executive, British Society for Immunology
- Professor Lotte Steuten, Vice-President and Head of Consulting, Office for Health Economics
- Professor Sharon Peacock, Chair, Genomics UK Consortium and Professor of Public Health and Microbiology, University of Cambridge & Dr Alessandro Carabelli, post-Doctoral Research Associate, Genomics UK Consortium
- Hugo Fry, Managing Director, Sanofi UK
- The Rt Hon Baroness Nicola Blackwood of North Oxford
- Sebastian Rees, Research and Events Assistant, Reform
|Tweets by @reformthinktank|
Latest News from
Digital Public Services: What's Next?19/01/2021 12:25:00
The challenges that arose with service delivery during COVID-19 – from lockdown and remote working to increased demand – further cemented the benefits of having the right digital infrastructure in place.
Reformer Thoughts: 'a New Deal For Prevention'11/01/2021 11:05:00
This Reformer Thoughts discusses the benefits of a preventative approach to public health and the obstacles that stand in the way of its realisation.
Reform Think Tank Responds to Electoral Commission Decision on Brexit Party Name Change07/01/2021 15:05:00
The Electoral Commission yesterday certified the Brexit Party’s application to rename itself ‘Reform UK’.
Towards a New Model of Prevention10/12/2020 12:33:00
This briefing gives an overview of the discussion at the event ‘Towards a new model of prevention’.
All Hands on Deck: Public Private Partnerships During Covid-1908/12/2020 12:33:00
This Reform Perspectives examines how government has worked with the private sector to respond to COVID-19.
Good For, Bad For: Reform's Spending Review 2020 Breakdown26/11/2020 12:33:00
Yesterday’s one-year Spending Review held few surprises. We knew the finances were exceptionally bad, and the latest OBR data confirms that: the ‘central’ scenario has the economy contracting by 11.3% this year, unemployment peaking at 7.5% and long-term GDP scarring at 3%.
A Global Science Superpower: The Future of Medicines Valuation18/11/2020 16:25:00
This briefing gives an overview of the discussion at the event, 'A global science superpower: the future of medicines valuation'.
Reform Responds to National Audit Office Covid-19 Procurement Report18/11/2020 12:33:00
Blog posted by: Aidan Shilson Thomas, 18 November 2020.